activity (in thousands) for the periods indicated:
During the three months ended March 31, 2025,
104,170
share-settled restricted stock units vested having an aggregate grant date fair value of $
11.4
million. During the three months ended March 31, 2024
,
60,020
share-settled restricted stock units having an aggregate grant date fair value of $
3.2
million vested, and
18,890
shares were withheld to satisfy tax obligations, resulting in
41,130
issued shares. The weighted average grant date fair value of share-settled restricted stock units granted during the
three months ended March 31, 2025 and 2024 was $
272.08
and $
145.17
, respectively, based on the fair value of the Company’s class A common stock.
For the three months ended March 31, 2025 and 2024, the Company recognized approximately $
5.2
million and $
4.7
million, respectively, in share-based compensation expense from share-settled restricted stock units granted under the Stock Incentive Plans. As of March 31, 2025, there was approximately $
81.4
million of total unrecognized share-based compensation expense related to unvested share-settled restricted stock units, which the Company expects to recognize over a weighted average vesting period of approximately
3.2
years.
Share-settled performance stock units
As of
March 31, 2025, there were
282,322
performance stock units outstanding under the 2023 Equity Plan. The following table summarizes the Company’s performance stock unit activity (in thousands) for the periods indicated:
18
The weighted average grant date fair value of performance stock units using the Monte-Carlo simulation model was $
445.66
and $
307.13
for each performance stock unit granted during the
three months ended March 31, 2025 and 2024, respectively, based on the following assumptions:
No
performance stock units vested during the
three months ended March 31, 2025 and 2024. For the three months ended March 31, 2025 and 2024, the Company recognized approximately $
0.7
million and $
1.1
million, respectively, in share-based compensation expense from performance stock units granted under the 2023 Equity Plan. As of March 31, 2025, there was approximately $
25.8
million of total unrecognized share-based compensation expense related to unvested performance stock units, which the Company expects to recognize over a weighted average vesting period of approximately
2.3
years.
Other stock-based awards and cash-settled restricted stock units
From time to time the Company has granted “other stock-based awards” and “cash-settled restricted stock units” under the 2013 Equity Plan. Other stock-based awards are similar to stock options, and cash-settled restricted stock units are similar to the Company’s share-settled restricted stock units, except in each case these awards are settled in cash only and not in shares of the Company’s class A common stock. Due to their required cash settlement feature, these awards are classified as liabilities in the Company’s Consolidated Balance